Viking Therapeutics, Inc. (VKTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$32.51
Day's range
$33.8

Viking Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 6.34 M $247.16 M   5.16% 5.47%
BLACKROCK, INC. 08/07/2026 6.19 M $241.46 M   -10.04% 5.34%
STATE STREET CORP 08/07/2026 5.61 M $218.71 M   27.55% 4.84%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 5.05 M $197.14 M   0.82% 4.36%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.48 M $174.93 M   0.45% 3.87%
TWO SIGMA INVESTMENTS, LP 08/14/2026 3.94 M $153.60 M   -11.16% 3.40%
MORGAN STANLEY 08/13/2026 3.49 M $135.99 M   15.66% 3.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 2.91 M $113.38 M   -7.96% 2.51%
AMERIPRISE FINANCIAL INC 08/14/2026 2.16 M $84.11 M   28.43% 1.86%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.10 M $81.87 M   0.76% 1.81%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.82 M $70.84 M   -12.63% 1.57%
D. E. SHAW & CO., INC. 08/14/2026 1.61 M $62.65 M   -4.22% 1.39%
DIADEMA PARTNERS LP 08/14/2026 1.22 M $47.62 M   85.19% 1.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.18 M $46.04 M   23.39% 1.02%
CITADEL ADVISORS LLC 09/02/2026 1.12 M $43.77 M   21.36% 0.97%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 981.70 K $38.30 M   81.63% 0.85%
CITADEL ADVISORS LLC 09/02/2026 951.52 K $37.12 M   -24.62% 0.82%
GOLDMAN SACHS GROUP INC 08/14/2026 942.84 K $36.78 M   -1.85% 0.81%
UBS GROUP AG 08/13/2026 936.06 K $36.52 M   -30.53% 0.81%
JPMORGAN CHASE & CO 08/12/2026 915.19 K $36.39 M   88.42% 0.79%
JANE STREET GROUP, LLC 08/14/2026 899.56 K $35.09 M   20.11% 0.78%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 816.37 K $31.85 M   15.66% 0.70%
RAYMOND JAMES FINANCIAL INC 08/14/2026 794.66 K $31.00 M   -61.71% 0.69%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 732.05 K $28.56 M   3.05% 0.63%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 730.69 K $28.50 M   -0.78% 0.63%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 730.69 K $28.50 M   100.00% 0.63%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 682.91 K $26.64 M   -1.92% 0.59%
VESTAL POINT CAPITAL, LP 08/14/2026 680.00 K $26.53 M   -25.61% 0.59%
NORTHERN TRUST CORP 08/13/2026 626.72 K $24.45 M   9.32% 0.54%
CITADEL ADVISORS LLC 09/02/2026 603.20 K $23.53 M   40.84% 0.52%
EVERSEPT PARTNERS, LP 08/14/2026 602.92 K $23.52 M   152.15% 0.52%
BLACKBARN CAPITAL PARTNERS LP 08/14/2026 600.00 K $23.41 M   -3.45% 0.52%
JUMP FINANCIAL, LLC 08/13/2026 579.88 K $22.62 M   100.00% 0.50%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 574.04 K $22.39 M   152.08% 0.50%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 540.05 K $21.07 M   -0.45% 0.47%
JANE STREET GROUP, LLC 08/14/2026 535.00 K $20.87 M   112.22% 0.46%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 530.61 K $20.70 M   2.81% 0.46%
CAPTION MANAGEMENT, LLC 08/14/2026 525.80 K $20.51 M   72.39% 0.45%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 500.00 K $19.51 M   0.00% 0.43%
MILLENNIUM MANAGEMENT LLC 08/14/2026 498.17 K $19.43 M   98.85% 0.43%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 494.51 K $19.29 M   -5.89% 0.43%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 473.31 K $18.46 M   100.00% 0.41%
CLEARBRIDGE INVESTMENTS, LLC 08/13/2026 444.78 K $17.35 M   0.00% 0.38%
DIADEMA PARTNERS LP 08/14/2026 441.81 K $17.23 M   -15.88% 0.38%
BLAIR WILLIAM & CO/IL 08/11/2026 416.77 K $16.26 M   12.30% 0.36%
BANK OF NEW YORK MELLON CORP 08/06/2026 407.84 K $15.91 M   -10.18% 0.35%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/14/2026 393.00 K $15.35 M   186.65% 0.34%
BANK OF AMERICA CORP /DE/ 08/14/2026 383.78 K $14.97 M   16.04% 0.33%
WALLEYE TRADING LLC 08/03/2026 383.60 K $14.96 M   5.47% 0.33%
FIRST WASHINGTON CORP 08/13/2026 381.30 K $14.87 M   -1.06% 0.33%

Viking Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 578 institutional investors and hedge funds held shares of Viking Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 6.34 M

BlackRock, Inc.: 6.19 M

STATE STREET CORP: 5.61 M

VANGUARD CAPITAL MANAGEMENT LLC: 5.05 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 4.48 M

TWO SIGMA INVESTMENTS, LP: 3.94 M

65.98% of Viking Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 98.27 M shares in the last 24 months. This purchase volume represents approximately $3.30 B in transactions.